SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-506911"
 

Search: onr:"swepub:oai:DiVA.org:uu-506911" > Knowledge support f...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Knowledge support for environmental information on pharmaceuticals : experiences among Swedish Drug and Therapeutics Committees

Linder, Elkanah (author)
Uppsala universitet,Institutionen för farmaci
Wettermark, Björn (author)
Uppsala universitet,Institutionen för farmaci
Ovesjö, Marie-Louise (author)
Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden.;Soder Sjukhuset, Dept Qual & Patient safety, Stockholm, Sweden.
show more...
Kälvemark Sporrong, Sofia (author)
Uppsala universitet,Institutionen för farmaci
Ramström, Helena (author)
Hlth & Med Care Adm, Stockholm, Region Stockhol, Sweden.
show less...
 (creator_code:org_t)
BioMed Central (BMC), 2023
2023
English.
In: BMC Health Services Research. - : BioMed Central (BMC). - 1472-6963. ; 23:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BackgroundTwo publicly available Swedish knowledge support systems, “Pharmaceuticals and Environment” on Janusinfo.se and Fass.se, provide environmental information on pharmaceuticals. Janusinfo is provided by the public healthcare system in Stockholm and Fass is provided by the pharmaceutical industry. The objectives of this study were to investigate the experiences among Swedish Drug and Therapeutics Committees (DTCs) with using the databases, retrieve development proposals for these, and investigate the DTCs’ challenges with working with pharmaceuticals in the environment.MethodsA cross-sectional survey with 21 questions, both closed and open-ended, was distributed electronically in March 2022 to Sweden’s 21 DTCs. Descriptive statistics and inductive categorization were used for the analysis.ResultsA total of 132 respondents from 18 regions filled out the survey. The average regional response rate was 42%. The DTCs used the knowledge supports to consider environmental aspects of pharmaceuticals in their formularies and in education. Respondents were more familiar with Janusinfo compared to Fass but appreciated the availability of both. The DTCs especially valued the concrete proposals for certain active pharmaceutical ingredients on Janusinfo. Respondents requested that all medicinal products have environmental information on Fass. Challenges included lack of data, lack of transparency from the pharmaceutical industry and difficulties considering the environmental aspect of pharmaceuticals in their healthcare practice. Respondents wanted more knowledge, clear messages, and legislation to support their work to reduce the negative environmental impact of pharmaceuticals.ConclusionsThis study demonstrates that knowledge supports for environmental information on pharmaceuticals are valuable for the DTCs in Sweden, but the respondents experienced challenges in their work in this field. The study can provide insights to those in other countries interested in considering environmental aspects in their formulary decision-making.

Subject headings

TEKNIK OCH TEKNOLOGIER  -- Naturresursteknik -- Miljöledning (hsv//swe)
ENGINEERING AND TECHNOLOGY  -- Environmental Engineering -- Environmental Management (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Samhällsfarmaci och klinisk farmaci (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Social and Clinical Pharmacy (hsv//eng)

Keyword

Drug and Therapeutics Committees
Environment
Survey
Pharmaceuticals
Knowledge support
Recommended medicines

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view